Found 25 matching trials
Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The purpose of this study is to evaluate the efficacy of Fixed Combination ...
Show More Location
Medical Center Convex EOOD
Learn More & Join Trial
Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease PHASE3 The purpose of this study is to determine the triple combination of beclome...
Show More Location
Institut für klinische Forschung
Learn More & Join Trial
Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients PHASE1 The study is performed to investigate the effect of the spacing device on t...
Show More Location
Medical University in Lodz
Learn More & Join Trial
Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR® PHASE1 The study is being conducted to compare the pharmacokinetic (PK) of BDP (an...
Show More Location
SGS Belgium NV - Clinical Pharmacology Unit
Learn More & Join Trial
CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD PHASE4 Double Blind, Multinational, Multicentre, Randomised, Placebo-Controlled, 3...
Show More Location
PAREXEL International GmbH Early Phase Clinical Unit Berlin
Learn More & Join Trial
Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers PHASE1 The study is performed to evaluate the total systemic exposure and lung bio...
Show More Location
SGS CPU Antwerpen
Learn More & Join Trial
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment. PHASE1 The study is performed to characterize the pharmacokinetics of glycopyrrola...
Show More Location
Biovirtus Research Site
Learn More & Join Trial
Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA PHASE4 The purpose of this phase IV Study is to compare the efficacy of CHF5993 (B...
Show More Learn More & Join Trial
Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) PHASE3 The purpose of the study is to demonstrate the triple combination of beclom...
Show More Location
Erzsebet Gondozohaz
Learn More & Join Trial
Drug-drug Interaction Study of CHF5993 With Cimetidine PHASE1 The purpose of this study is to evaluate the pharmacokinetic interaction wh...
Show More Location
Life Science Services SGS Belgium NV
Learn More & Join Trial